Dr. Jeff Allen has over 20 years of experience in biotechnology, analyzing complex biological problems and then combining new and existing technologies to create innovative solutions. He obtained his Ph.D. in Analytical Chemistry at Arizona State Univeristy and a BS in Biochemistry from the University of Massachusetts, Amherst. Dr. Allen has used his scientific training throughout his career at Beckman (Coulter), Gen-Probe (Hologic) and BD.  Jeff's special skill set is to combine both technical and business expertise to launch new molecular based systems. The same combination of skills sets is now being applied to help find a cure for cancer. Dr. Allen has assembled a team of exceptional scientists with expertise in many different areas and given them a single focus; identify and capture metastatic cell clusters, The Root Cause of Cancer Metastasis.

Peter is Sr. Director and Head of Lead Discovery at Ideaya Biosciences, where he leads a team identifying small molecule drugs against cancer targets, with a specific focus on synthetic lethality.

He received his D.Phil. in biophysics and biochemistry from the University of Oxford, United Kingdom, in 2004. Dr. Teriete was the lead scientist in solving the solution structure of the hyaluronan binding domain of the leukocyte homing receptor CD44. Dr. Teriete has published over 40 peer-reviewed research articles investigating relevant proteins for structure determination efforts, their role as bio-markers for prognosis in cancer, and as target to develop novel and potent therapeutics. Peter has been part of a team that brought multiple drugs to the clinic and has a deep understanding of the drug discovery and development process.